Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of PA9159 Inhalation Aerosol in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of PA9159 inhalation aerosol in healthy adult subjects. The study assesses potential use…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PA9159 inhalation aerosol (PA9159)

Snippet

Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. | Conditions: Bronchial Asthma | Phase 1 | Status: COMPLETED